Author: Carsten Bokemeyer
Publisher: Elsevier Science Health Science Division
ISBN: 9780080445755
Category : Medical
Languages : en
Pages : 304
Book Description
Anaemia in Cancer
Author: Carsten Bokemeyer
Publisher: Elsevier Science Health Science Division
ISBN: 9780080445755
Category : Medical
Languages : en
Pages : 304
Book Description
Publisher: Elsevier Science Health Science Division
ISBN: 9780080445755
Category : Medical
Languages : en
Pages : 304
Book Description
Anemia
Author: Edward J. Benz (Jr.)
Publisher:
ISBN: 9781108425209
Category :
Languages : en
Pages :
Book Description
Publisher:
ISBN: 9781108425209
Category :
Languages : en
Pages :
Book Description
Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology
Author: Mohammad Resa Nowrousian
Publisher: Springer Science & Business Media
ISBN: 3709176581
Category : Medical
Languages : en
Pages : 524
Book Description
Anemia is a frequent complication of cancer and its treatment. A number of clinical studies shows that the impact of anemia is much greater than previously thought. Beyond clinical symptoms, anemia significantly impairs physical and metabolic functions as well as patients' activity, well-being and quality of life. Life expectancy is also affected. In this book, written by a group of outstanding international experts, the current knowledge on anemia in cancer and its treatment with rhEPO is presented. Future developments are also discussed. Based on a broad spectrum of topics, the book describes the scientific and clinical aspects of anemia in various fields of oncology and gives diagnostic and therapeutic recommendations on when and how to use rhEPO.
Publisher: Springer Science & Business Media
ISBN: 3709176581
Category : Medical
Languages : en
Pages : 524
Book Description
Anemia is a frequent complication of cancer and its treatment. A number of clinical studies shows that the impact of anemia is much greater than previously thought. Beyond clinical symptoms, anemia significantly impairs physical and metabolic functions as well as patients' activity, well-being and quality of life. Life expectancy is also affected. In this book, written by a group of outstanding international experts, the current knowledge on anemia in cancer and its treatment with rhEPO is presented. Future developments are also discussed. Based on a broad spectrum of topics, the book describes the scientific and clinical aspects of anemia in various fields of oncology and gives diagnostic and therapeutic recommendations on when and how to use rhEPO.
Uses of Epoetin for Anemia in Oncology
Anaemia in Cancer
Author: Carsten Bokemeyer
Publisher: Elsevier Science Health Science Division
ISBN: 9780444509048
Category : Medical
Languages : en
Pages : 227
Book Description
This volume provides a comprehensive, state-of-the-art overview of the pathogenesis, treatment and treatment effects of chronic anaemia of cancer as well as chemotherapy- and radiotherapy-induced anaemia. It is the result of a joint effort by the members of the European School of Oncology (ESO) Task Force on Anaemia in Cancer and the participants of an ESO Symposium on this topic. negative prognostic factor for clinical outcome in cancer patients. In addition, there is evidence that tissue hypoxia contributes to the progression of malignant disease by inducing a more malignant phenotype, stimulating angiogenesis within tumour tissues, and diminishing the sensitivity of tumour cells to chemotherapy and radiation therapy. traditional treatment for anaemia - the transfusion of red blood cells - has significant limitations. This situation has changed dramatically with the introduction of recombinant human erythropoietin, which acts as an important physiological stimulator of human erythropoiesis. The beneficial effects of erythropoietin markedly exceed those of transfusions. Erythropoietin can lead to complete, long-term normalization of anaemia which in turn results in a significant improvement in anaemic cancer patients' quality of life and physical exercise capacity.
Publisher: Elsevier Science Health Science Division
ISBN: 9780444509048
Category : Medical
Languages : en
Pages : 227
Book Description
This volume provides a comprehensive, state-of-the-art overview of the pathogenesis, treatment and treatment effects of chronic anaemia of cancer as well as chemotherapy- and radiotherapy-induced anaemia. It is the result of a joint effort by the members of the European School of Oncology (ESO) Task Force on Anaemia in Cancer and the participants of an ESO Symposium on this topic. negative prognostic factor for clinical outcome in cancer patients. In addition, there is evidence that tissue hypoxia contributes to the progression of malignant disease by inducing a more malignant phenotype, stimulating angiogenesis within tumour tissues, and diminishing the sensitivity of tumour cells to chemotherapy and radiation therapy. traditional treatment for anaemia - the transfusion of red blood cells - has significant limitations. This situation has changed dramatically with the introduction of recombinant human erythropoietin, which acts as an important physiological stimulator of human erythropoiesis. The beneficial effects of erythropoietin markedly exceed those of transfusions. Erythropoietin can lead to complete, long-term normalization of anaemia which in turn results in a significant improvement in anaemic cancer patients' quality of life and physical exercise capacity.
Pathophysiology and Pharmacology of Erythropoietin
Author: Horst Pagel
Publisher: Springer Science & Business Media
ISBN: 3642770746
Category : Medical
Languages : en
Pages : 318
Book Description
The book contains a series of about 40 articles reflecting the state-of-the-art of the topic "Pathophysiology and Pharmacology of Erythropoietin". Results from both basic research and clinical studies are described in detail. The papers show that the possible therapeutic spectrum of erythropoietin could be expanded considerably when compared with the present situation.
Publisher: Springer Science & Business Media
ISBN: 3642770746
Category : Medical
Languages : en
Pages : 318
Book Description
The book contains a series of about 40 articles reflecting the state-of-the-art of the topic "Pathophysiology and Pharmacology of Erythropoietin". Results from both basic research and clinical studies are described in detail. The papers show that the possible therapeutic spectrum of erythropoietin could be expanded considerably when compared with the present situation.
Exercise Oncology
Author: Kathryn H. Schmitz
Publisher: Springer Nature
ISBN: 3030420116
Category : Medical
Languages : en
Pages : 438
Book Description
This groundbreaking book presents a unique and practical approach to the evolving field of exercise oncology - the study of physical activity in the context of cancer prevention and control. Presenting the current state of the art, the book is sensibly divided into four thematic sections. Following an opening chapter presenting an overview and timeline of exercise oncology, the chapters comprising part I discuss primary cancer prevention, physical activity and survivorship, and the mechanisms by which these operate. Diagnosis and treatment considerations are discussed in part II, including prehabilitation, exercise during surgical recovery, infusion and radiation therapies, and treatment efficacy. Post-treatment and end-of-life care are covered in part III, including cardio-oncology, energetics and palliative care. Part IV presents behavioral, logistical and policy-making considerations, highlighting a multidisciplinary approach to exercise oncology as well as practical matters such as reimbursement and economics. Written and edited by experts in the field, Exercise Oncology will be a go-to practical resource for sports medicine clinicians, family and primary care physicians, oncologists, physical therapy and rehabilitation specialists, and all medical professionals who treat cancer patients.
Publisher: Springer Nature
ISBN: 3030420116
Category : Medical
Languages : en
Pages : 438
Book Description
This groundbreaking book presents a unique and practical approach to the evolving field of exercise oncology - the study of physical activity in the context of cancer prevention and control. Presenting the current state of the art, the book is sensibly divided into four thematic sections. Following an opening chapter presenting an overview and timeline of exercise oncology, the chapters comprising part I discuss primary cancer prevention, physical activity and survivorship, and the mechanisms by which these operate. Diagnosis and treatment considerations are discussed in part II, including prehabilitation, exercise during surgical recovery, infusion and radiation therapies, and treatment efficacy. Post-treatment and end-of-life care are covered in part III, including cardio-oncology, energetics and palliative care. Part IV presents behavioral, logistical and policy-making considerations, highlighting a multidisciplinary approach to exercise oncology as well as practical matters such as reimbursement and economics. Written and edited by experts in the field, Exercise Oncology will be a go-to practical resource for sports medicine clinicians, family and primary care physicians, oncologists, physical therapy and rehabilitation specialists, and all medical professionals who treat cancer patients.
Hypoxia
Author: Robert C. Roach
Publisher: Springer Science & Business Media
ISBN: 9780306466960
Category : Medical
Languages : en
Pages : 466
Book Description
Hypoxia remains a constant threat throughout life. It is for this reason that the International Hypoxia Society strives to maintain a near quarter century tradition of presenting a stimulating blend of clinical and basic science discussions. International experts from many fields have focused on the state-of-the-art discoveries in normal and pathophysiological responses to hypoxia. Topics in this volume include gene-environment interactions, a theme developed in both a clinical context regarding exercise and hypoxia, as well as in native populations living in high altitudes. Furthermore, experts in the field have combined topics such as skeletal muscle angiogenesis and hypoxia, high altitude pulmonary edema, new insights into the biology of the erythropoietin receptor, and the latest advances in cardiorespiratory control in hypoxia. This volume explores the fields of anatomy, cardiology, biological transport, and biomedical engineering among many others.
Publisher: Springer Science & Business Media
ISBN: 9780306466960
Category : Medical
Languages : en
Pages : 466
Book Description
Hypoxia remains a constant threat throughout life. It is for this reason that the International Hypoxia Society strives to maintain a near quarter century tradition of presenting a stimulating blend of clinical and basic science discussions. International experts from many fields have focused on the state-of-the-art discoveries in normal and pathophysiological responses to hypoxia. Topics in this volume include gene-environment interactions, a theme developed in both a clinical context regarding exercise and hypoxia, as well as in native populations living in high altitudes. Furthermore, experts in the field have combined topics such as skeletal muscle angiogenesis and hypoxia, high altitude pulmonary edema, new insights into the biology of the erythropoietin receptor, and the latest advances in cardiorespiratory control in hypoxia. This volume explores the fields of anatomy, cardiology, biological transport, and biomedical engineering among many others.
Aplastic Anemia
Author: Hubert Schrezenmeier
Publisher: Cambridge University Press
ISBN: 9780521641012
Category : Medical
Languages : en
Pages : 410
Book Description
Comprehensive and up-to-date clinical reference, with an emphasis on treatment.
Publisher: Cambridge University Press
ISBN: 9780521641012
Category : Medical
Languages : en
Pages : 410
Book Description
Comprehensive and up-to-date clinical reference, with an emphasis on treatment.
Anemia in the Elderly
Author: Lodovico Balducci
Publisher: Springer Science & Business Media
ISBN: 0387495061
Category : Medical
Languages : en
Pages : 148
Book Description
Anemia in the elderly has been properly defined as the silent epidemic, representing 3 million people in the United States aged 65 years and older. Incidence and prevalence of this condition increase with age. It differs in its etiology, pathogenesis and treatment from anemia in children and younger adults. Anemia is associated with reduced survival, increased risk of functional dependence and hospitalization, increased risk of congestive heart failure and stage renal disease and cognitive disorders. Approximately 70% of anemia in older individuals is reversible.
Publisher: Springer Science & Business Media
ISBN: 0387495061
Category : Medical
Languages : en
Pages : 148
Book Description
Anemia in the elderly has been properly defined as the silent epidemic, representing 3 million people in the United States aged 65 years and older. Incidence and prevalence of this condition increase with age. It differs in its etiology, pathogenesis and treatment from anemia in children and younger adults. Anemia is associated with reduced survival, increased risk of functional dependence and hospitalization, increased risk of congestive heart failure and stage renal disease and cognitive disorders. Approximately 70% of anemia in older individuals is reversible.